Evaluation of the Migraceutics® Phase-Specific Dietary Supplement Regimen on Quality of Life, Work Productivity, and Biomarkers in Adult Migraineurs: The Migraceutics® START Study

A Randomized, Sham Supplement- and Care-as-Usual-Controlled Study to Evaluate Migraceutics® Phase-Specific Dietary Supplement Regimen on Quality of Life, Work Productivity, and Biomarkers in Adult Migraineurs: The Migraceutics® START Study

The purpose of this study is to evaluate the impact of the Migraceutics® phase-specific dietary supplement regimen on quality of life, work productivity, and biomarkers in adult migraineurs.

Inclusion Criteria:

• Self-reported history of migraine, based on the International Headache Society (IHS) International Classification of Headache Disorders, 3rd edition (ICHD-3) diagnostic criteria for migraine.
• Being able to take oral supplements.
• Agreeing to maintain their regular lifestyle.
• Access to internet and telephone.

Exclusion Criteria:

• Pregnancy or lactation.
• Presence of any active medical condition or diagnosis other than episodic migraine, including liver or kidney disease or condition.
• Use of overlapping supplements or interacting medications.
• Known allergies to study ingredients.
• Daily use of alcohol, tobacco, or recreational drugs.
• Participation in any other clinical or interventional study within 30 days prior to baseline or concurrently.